3rd BSCA Conference – SSF, 2010

BIOTECH INDUSTRY LEADERS FROM AROUND THE WORLD WILL GATHER IN SOUTH SAN FRANCISCO, CALIFORNIA, TO ADDRESS IMPROVING THE GLOBAL SUPPLY CHAIN TO MAXIMIZE PATIENT CARE

San Francisco, California (March 20, 2010): The world’s leading community for biotechnology supply chain professionals will be meeting at the Embassy Suites in South San Francisco on October 26, 2010, for the 3rd annual Biotech Supply Chain Academy conference.  The expanded multi-track conference titled “Transforming the Global Supply Chain for End-to-End Visibility and Quality Patient Care” will be identifying and developing supply chain solutions for the industry’s expanding world presence with a clear focus on patient care.  The Call for Papers requests expert speakers to present on topics enumerated below and others deemed pertinent and valuable. The deadline for paper submissions is August 1, 2010.

Industry and Academia leaders from around the world will present a large slate of sessions designed to increase collaboration and cooperation between suppliers, manufacturers, distributors, and providers. The focus of the conference will be the Top 10 issues facing the biotech industry:

  1. Biotech Industry Research from Wall Street, Venture Capital and Manufacturing Industry Experts

  2. Development of Supply Chain Talent Management: Practices from the Best in Other Industries and Academia

  3. Creating the Patient-focused Supply Chain: Best Practices for the Identification, Measurement, and Execution of Risk Management

  4. Information Technology Management: The Holy Grail! Technical Solutions to Enable Procure to Pay and ePedigree

  5. Global Strategic Sourcing: Sourcing Development Strategies in a Collaborative Environment to Maximize Supplier and Vendor Relationships

  6. Visibility in the Supply Chain: Proven Solutions from End-to-End

  7. Cash Management: Ensuring the Financial Bottom Line of SCM

  8. Applying Lean Six Sigma and QA to Optimize Patient Care and Eliminate Waste

  9. Cold Chain & Logistics Management: Technologies and Best of Breed Case Studies

  10. CRO, CMO, R&D and Business Analytics Services: The New Outsourcing Frontiers of India, China and Europe

“The executive and academic leaders of the biotech industry have built a strong foundation for the discussion of challenges, exchange of solutions, and implementation of advancements in the supply chain in an open, collaborative manner,” says Devendra Mishra, the executive director of the Bio Supply Management Alliance (BSMA) and adjunct professor of Pepperdine University’s Graziadio School of Business & Management.  “Today they are committed to fostering the mission of improving the efficacy of the end-to-end supply chain by reducing the drug development pipeline cost and time line through global synergies and developing highly capable supply chain management talent for higher quality patient care.”

2010 Conference Program

Location:  South San Francisco

Untitled Document

7:30-8:30

REGISTRATION/GOLDEN GATE BALLROOM

8:30-8:35

WELCOME: Devendra Mishra, Executive Director, Bio Supply Management Association (BSMA)

8:35-9:00

KEYNOTE: Healthcare – Prospering in a Post-reform World

One of the most important pieces of health legislation since Medicare is now the law of the land. This presentation will discuss the impact to the value chain stakeholders and suggestions for their blueprint to derive long-term value. Healthcare value chain executives (providers, payers, retailers, distributors, and life sciences) will have to work quickly to position their organizations for the post-reform world to respond to the challenge of new taxes, new regulations, and new administrative deadlines.

Karen Conway, Director – Industry Programs, Global Health Exchange (GHX)

9:00-9:30

Uncovering the Unique Competencies of the Top 25 Healthcare Companies

The first AMR Research Healthcare Top 25 for 2009 recognizes those life sciences and healthcare companies – manufacturers, distributors, pharmacies and hospitals, which have demonstrated leadership in developing and leveraging supply chain capabilities. The Bottom Line: Johnson & Johnson, one of the world’s foremost healthcare companies, is No. 1, followed by Sisters of Mercy, a hospital system that is leading the way for supply chain transformation at the patient level. The secrets of their success will be identified along with best practices and strategies deployed as Healthcare companies must stem the cost of incoming supplies and deal with decreasing reimbursement for their products and services.

Wayne McDonnell, Research Director, Healthcare & Life Science, Gartner

9:30-10:15

PANEL: Industry 360° – Transforming The Industry End To End

Stakeholders of the industry – Manufacturers, Wholesale Distributors, Retail Pharmacies, Hospitals and Healthcare Providers, discuss challenges, exchange solutions and collaborate to advance the supply chain in terms of productivity, quality, customer service and technology. Other salient issues of linkage of manufacturers with providers, outsourcing,
distribution network design and management, logistics strategies and best practice will be addressed.

Panelists:

Alison Moore, Vice President Corporate Manufacturing, Amgen

Andy Ramelmeier, Vice President, Manufacturing and Process Development, Bio-Marin

Chris Horan, Vice President, Supply Chain, North America, Genentech

Doug Witter, Vice President, Sales and Marketing, OM Healthcare Logistics, Owens & Minor HealthCare

Jason Birnbaum, CIO, GE Global Supply Chain, GE Healthcare

Vance Moore, President and CEO, Resource Optimization and Innovation (Sisters of Mercy)

Moderator: Wayne McDonnell, Research Director. Life Sciences, Gartner

10:15-10:30

NETWORKING BREAK SPONSORED BY BAYER HEALTHCARE – BALLROOM

10:30-11:00

Working Capital Management in the Global Enterprise: The Bottom Line!

Management of working capital inventory, assets, receivables and payables, is a vital imperative of business. Presentation will address the challenges and solutions of optimization in a global, volatile network of manufacturing,

distribution and retail. Implementation of forecasting systems, measurement techniques, metrics, visibility and management dash boards will be discussed.

Thomas Panzer, Vice President Global Supply Chain PS-Biotech, Bayer Healthcare

11:00-11:30

KEYNOTE: Single-source, Integrated Supply Chain Services for Healthcare

As an operating division of the Sisters of Mercy Health System, ROi is one of the healthcare industry’s leading single-source, fully-integrated supply chain management companies, providing purchasing, product and pharmaceutical distribution services, and custom procedure tray manufacturing. Presentation covers how technology and the principles of collaboration, innovation, alignment and service improve the clinical, operational and financial strength of its customers. Mercy/ROi was recognized as the National Award Winner for the 2010 Search for Supply Chain Excellence Award conducted by AMR Research.

Vance Moore, President and CEO, Resource Optimization & Innovation (Sisters of Mercy)

11:30-12:00

Transforming Enterprise Level Supply Chain of Biological Entities

This session will describe an enterprise-class biological entity management system Infosys has co-created with a bio-pharmaceutical client to accelerate the biologics research, and streamline the innovation process. This system enables
biologists to register biological entities uniquely, manage associated processes, track inventory effectively, request and fulfill stock efficiently, and also enhance tracking and tracing of intellectual property related to such

entities. It will bring together scientists from different parts of the research value chain and in different sites, reduce redundancies in research transactions, accelerate the innovation processes, and lower operational costs dramatically.

R. Arun Kumar, Industry Head-Global Life Sciences, Infosys

12:00-1:15

NETWORKING LUNCH – Ballroom

12:30-1:00

Special Presentation: California ePedigree: the Legal Requirements
Background and Contours of the California Electronic Pedigree Requirements – Existing Law, Timelines for Implementation, and Next Steps.

Joshua Room, Deputy Attorney General, California Department of Justice, Office of the Attorney General

5:00-5:30

Keynote: Biotech Industry Supply Chain: A Vision of the Future With a Blueprint for Results

Based on a situational analysis of the industry with recognition of the points of inflexion and the thought leadership at the Conference, a road map will be provided for major initiatives to positively impact the supply chain which the stakeholders can implement through collaboration.

Speaker

Dave Malenfant

Vice-President

Global Supply Chain

Alcon Laboratories

5:30-7:00

DINNER RECEPTION SPONSORED BY MCKESSON
 

EVENT SPONSORS

 

APICS Golden Gate Chapter

 

Cornerstone Systems Solutions

 

GOLD SPONSOR

 

Infosys

 

SILVER SPONSOR

EnviroCooler

 

BRONZE SPONSORS

 

GHX Healthcare Supply Chain Management

 

NexInfo Supply Chain Architects

 

RECEPTION SPONSOR

 

McKesson

 

PARTICIPATING SPONSORS

 

Intelleflex

 

Langham Logistics

 

Oracle Life Sciences

 

PRTM

ACADEMIC SPONSOR

Pepperdine University

 

MEDIA SPONSORS

 

ISTA North America

 

 

 

World Trade 100

ASSOCIATION SPONSORS

 

 
 
Council of Supply Chain Management Professionals Bay Area

 

Institute for Supply Management

 

Women In Logistics Northern California

 

ARCHIVE LIBRARY

 

Click Here for Archived Documents

 

 

 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

Track 1-Ballroom

 

Track 2 – Tiburon

 

Track 3 – Presidio

Strategic Sourcing & Risk Management

 

 
Leveraging Technology & Key Partners in the Supply Chain
 
Talent Development, Cold Chain & Sustainability

1:15-1:45 Progression From Tactical Purchasing to Strategic Sourcing

                   

As the biopharmaceutical industry has grown and evolved, its procurement practices have essentially stalled in the tactical purchasing mode, with most companies focused on how to be more efficient with issuing purchase orders, managing contracts and issuing one-way supplier assessments. A proven case study will be presented of strategic sourcing and category management to address significant cost savings, partnerships for product development and launch, and supply risk management.

Speaker

Paul Anderson

Vice President

Global Procurement LifeTechnologies

 

1:15-1:45 Rewiring the Biotech Supply Chain: The Holy Grail

The best information and systems technology requirements to meet the complex technology needs of the biotech and pharma supply chain community consisting of the manufacturers, distributors, retail pharmacies and hospitals require synchronization, connectivity and sharing of information.

Speakers

Bruce Sawyer

Senior Director, Process Excellence

Johnson & Johnson

Pramod John

Vice President

IT Strategy and Innovation McKesson

 

1:15-1:45 Education Empowering People Excellence and World Class Performance

Widespread APICS education and the process of obtaining Class A certification in manufacturing at Genentech has revolutionized planning and scheduling in biotech plants by meeting demand and decreasing cost of goods at the same time. Two of the key initiatives implemented were APICS education for the planning and scheduling groups, in addition to manufacturing personnel in general, and the quest for Class A certification and world class performance. APICS methodology has been the key to the development of one and two-day classes for senior manufacturing executives and also Class A certification.

Speakers

Keith Launchbury, CFPIM
Past President, APICS The Association for Operations Management

Muffie Dalton, CPIM
Team Leader
Drug Product Plant Scheduling

Genentech

1:45-2:30 PANEL: Combating Cost, Quality, Reliability and Speed to Market in Sourcing Products & Services Globally

Sourcing executives of the industry will present a proven approach for building supplier relations management in the global market place, required organizational structures and responsibilities, strategy to deal with single sourcing, best of breed practices from other industries, information systems for intelligent decision making and cross-disciplinary experiences.

Panelists

Mark Buck

Global Procurement and Supply Leader

Bio-Rad Laboratories

Mike Mitchell

Director

Global Supply Chain Management

SAFC Bioscience

Dale Dwier

Manager

Procurement, Direct Materials

Bayer Healthcare

Isaac Young

Senior Director

Supply Chain Operations

BioMarin Pharmaceuticals

Paul Anderson

Vice President

Global Procurement

Life Technologies

Moderator:

William Coakley

Senior Director

Supply Chain Management

SciClone Pharmaceuticals

 

1:45-2:15 Pharma Industry Report: 2015 Readiness for Track and Trace

GS1 Healthcare US’s Secure Supply Chain Task Force has developed a pharmaceutical supply chain model as part of a program known as 2015 Readiness. The model is intended to prepare members of the U.S. pharmaceutical supply chain to use a standard serialized track-and-trace system (known as an electronic pedigree) related to the movements of items. Since January 2010, 50 companies have utilized a simulated supply chain to map out a supply chain and send items with unique ID numbers, either on RFID tags or on 2-D bar codes. The program aims to develop a model for anyone in the pharmaceutical industry who is responsible for IT, logistics or packaging, as well as manufacturers, retail pharmacies and wholesalers.

Speaker

Robert Celeste

Director

GS1 Healthcare US

 

1:45-2:15 PANEL: Meeting the Talent Development Challenges of the Biotech Industry

How best to develop the organization structure, career paths, educational training programs to increase the capabilities and skills to support the growth of the biotech industry remains its greatest challenge. Academicians, human resource personnel for management development, management recruiters and supply chain and operations executives of the industry present successful endeavors in various industries and apply them to biotech.

Panelists

Muffie Dalton

Team Leader

Drug Product Plant Scheduling

Genentech

Phil Kaminsky

Associate Professor

School of IE & OR

UC Berkeley

Adam Zak

CEO

Adam Zak Executive Search

Moderator:

Dave Malenfant

Vice President

Global Supply Chain

Alcon Laboratories

2:30-2:50 The Amplification Effects of Supply Chain Risks to Impact Shareholder Value – How Should this Affect a Business Strategy?

The complexity of today’s supply chain and operational risks can have a profound amplification effect on the ability to supply products to patients or consumers, and quickly erode shareholder value. Industrial situations will be presented to demonstrate how these risks influence long term supply and business strategies.

Speakers

Chris Sam

Executive Director

Craigshannock

(former head of Operations Risk Management, Amgen)

Vijay Chiruvolu

Director

Risk Management

Amgen

 

2:15-2:45 Timing and Tactics for Serialization 2015: From Traceability to Pedigree

With the California ePedigree laws implementation date of 2015, now is the time to begin planning for the operational and capital requirements of unit level serialization.  What are the requirements? What are the options for meeting them? Learn from our experiences reading 2D Barcodes and exchanging pedigree information.  Converting a production line to handle unit level serialization is a time consuming endeavor.  Learn from pilot work that has taken place over the past few years what works and the challenges you will face. What are the resources you can draw on going forward?

Speakers

Ron Bone

Senior Vice President

Distribution Support

McKesson

Lew Kontnik

Director

Brand Protection

Amgen

 

2:15-3:00 PANEL: Implementing ISTA 7E & Standard 20: The First Global Method for Establishing the Performance of ISCs

This session will provide an in-depth look at the rationale and reasoning behind the new set of Global Standards released by the International Transit Authority on September 22nd 2010. ISTA Standard 20 is the first global method for establishing ISC performance and houses the first set of statistically validated global thermal profiles – ISTA 7E Thermal Profiles.  ISTA Standard 14 the process by which laboratories can become ISTA Certified to perform ISC testing under the new Standard 20. The panelists will present each standard as they apply to the Industry, Supplier, and Auditor

Panelists

Brian Wallin

Senior Packaging Engineer

Cold Chain Engineering

Amgen

Don Wilson

Senior Engineering Manager

Packaging & Containers

Amgen

Gary Hutchinson

Director

Global Transportation

Amgen

Gordon L. Johnson II

Head of Strategic Innovation

LifeConEx

Jim Cox

MJ Enterprises

ISTA

Moderator:

Rod Derifield

President

Envirocooler

2:50-3:10 Key Learnings from Building a Raw Material Sourcing Risk Management Program

The case study introduces tools, process and general approach in building a raw material risk management program, with a focus on identification of high risk/impact items and implementation of appropriate risk mitigation strategies. Success factors and potential pitfalls in implementing material risk management program will also be discussed.

Speaker

Yingming Yue, CPIM

Associate Director

Supplier Management

Nektar Therapeutics

 

2:45-3:15 Mass Serialization for Track & Trace and ePedigree Based on 2D Matrix Code

Bayer Healthcare task force has responded to numerous coding initiatives worldwide, e.g. the California Pedigree Law, the European EFPIA initiative, Ministry of Heath requirements in Turkey, France, etc. To comply with the upcoming requirements, a core system based on the 2D Matrix Code has been developed, including packaging line equipment as well as a database system to handle mass serialization.

Speaker

Christian Riediger

Schering Pharma AG

Berlin, Germany

 

3:00-3:45 PANEL: Future of the Cold Chain Supply Chain: Convergence, Emergence, and Standardization

Presentation of some of the most forward-thinking and innovative thought-leaders in the Industry to provide not only of thoughts and visions of how technology, processes, standards, and products will evolve over the next 20-50 years, but also to identify potential obstacles. The interactive session will enable brain-storming with thought leaders on how we can all join solve the conundrums that lie ahead!

Panelists

Don Wilson

Senior Engineering Manager

Packaging & Containers

Amgen

Gary Hutchinson

Director

Global Transportation

Amgen

Gordon L. Johnson II

Head of Strategic Innovation

LifeConEx

Jim Cox

MJ Enterprises

ISTA

Rod Derifield

President

Envirocooler

3:10-3:30 When Something goes wrong with our supply chain, are we prepared to respond?

This session will explore three different scenarios where in a seemingly small, routine issue snowballs into a supply chain breakdown. Audience participation will be solicited, to derive at a better decision. Large and small companies alike will come away from this risk management exercise with a fresh look at how to be better prepared when something does go wrong.

Speakers

Carla Reed

Principal

Tunnell Consulting

Jane Lavine

Life Sciences RM Consultant

(former VP, Life Science Practice)

Marsh

Mohinder Sikka

CEO

Sensitel

 

3:15-3:30 2010 Biopharmaceutical Supply Chain Benchmarking Survey Results

Results will be presented of a supply chain assessment of 12 major bio-pharmaceutical companies in the areas of inventory management, delivery performance, cycle times, complexity and cost. The study helps supply chain executives identify the operational levers that needs to be managed, the critical trade-offs that need to be considered in decision-making and the competencies that must be instituted for superior supply chain performances. Key relevant best practices from outside the industry will also be presented.

Speakers

Vitaly Glozman

Director

PRTM Healthcare Practice

Michael Rusignola

Manager

PRTM Healthcare Practice

   
3:30-4:00 NETWORKING BREAK SPONSORED BY BAYER HEALTHCARE  – GOLDEN GATE BALLROOM

4:00-4:45 Panel: Supply Chain Risk Management – Current Practices and Future Focus

Discussion on various initiatives companies are focusing on to manage supply risk. The discussion will be on diverse risk management topics based on the prior presentations and additional feedback
received from the audience.

Panelists

Vijay Chiruvolu

Director

Risk Management

Amgen

Dennis Murphy

Vice-President, Fremont Site

Amgen

Chris Sam

Executive Director

Craigshannock

Thomas Smith

Director

Supply Chain

Shire Pharmaceuticals

Yingming Yue, CPIM

Associate Director

Supplier Management

Nektar Therapeutics

Moderator:

Arun Cavale

Principal

NexInfo

 

4:00-4:30 CMO/CRO Opportunities in India

The biotechnology industry faces significant issues relating to long gestation periods, high costs of development and manufacturing, regulatory hurdles, diverse competency needs, emerging competition from biosimilars and, above all, funding constraints. Outsourcing addresses many of these issues in functional domains across the value chain, as well as in business domains. Presentation will focus on India which offers several advantages in outsourcing in biotechnology – a large home market enabling scale, less obscure regulatory pathway, a patient pool well-suited to clinical trials, faster time to market in clinical development, access to competencies, competitive contract manufacturing and lower costs, while it has some limitations.

Speaker

K. V. Subramaniam

President & CEO

Reliance Int’l Life Sciences

India

 

4:00-4:30 Sustainability of the Environment: A Profitable Strategy!

A proactive approach to ensuring sustainability of the environment augurs well for the biotech industry as it has a positive impact on manufacturing and distribution efficiencies, customer service, trading partner relationship, waste disposal and recycling.

Speakers

David Windsheimer

Vice President

Global Logistics

Life Technologies

 

 

4:30-5:00 Realizing the Executive S&OP Vision

Risk management is required from the launch of a new product to building a new manufacturing facility and delivering prescription drugs to patients. At every stage, managers have a significant role in assessing, evaluating, and managing risk, using tools and techniques that have been used in other industries and disciplines.  Case studies of successful applications will focus on assessment and mitigation of enterprise risk.

Speakers

Jerry Battenber

Vice-President

Beckman Coulter

Arun Cavale

Principal

Nexinfo

 

4:30-5:00 Improving Cold Chain Visibility

Increasing costs and regulations requires improved cold chain visibility to ensure product integrity. In-transit temperature monitoring provides suppliers, shippers and end users with the info they need to make timely and accurate decisions and create sustainable improvements to reduce waste and costs.

Speaker

Peter Mehring

President and CEO

Intelleflex Corporation